8-K ·Filed Apr 7, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor for any shifts in board dynamics or strategic direction ahead of the 2026 Annual Meeting, but no trading catalyst expected from this routine governance update.
Final — all horizons settled through T+60d
COLL ▲ +10.77% at T+60d
NEUTRAL call ✓ call won +10.77% · α vs SPY +0.31% · entry $33.43 → $37.03
T+1d
+5.44%
call +5.44% · α +4.87%
$35.25
settled 6mo ago
T+5d
+4.49%
call +4.49% · α +0.97%
$34.93
settled 6mo ago
T+20d
+5.65%
call +5.65% · α -2.89%
$35.32
settled 5mo ago
T+60d
+10.77%
call +10.77% · α +0.31%
$37.03
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Collegium Pharmaceutical announced the nomination of Michael Donovan to its board of directors and the retirement of director John Fallon at the 2026 Annual Meeting. Fallon's departure is part of board refreshment and not due to disagreement.
Key Facts
- Michael Donovan, former EY audit partner with life sciences expertise, nominated to board
- Dr. John Fallon to retire from board after serving since 2016
- No CEO/CFO departure or executive change involved
- Board refreshment cited as reason for transition
Financial Impact
No immediate financial impact disclosed
governanceboard composition
Risk Factors
- Potential loss of medical expertise with Dr. Fallon's departure
- Board transition risk if new member lacks industry-specific experience
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-024061 |
| Document: 0001628280-26-024061-index-headers.html | 0001628280-26-024061 |
| Document: 0001628280-26-024061-index.html | 0001628280-26-024061 |
| Document: 0001628280-26-024061.txt | 0001628280-26-024061 |
12 reports for COLL
25% Hit rate best @ T+1▲ +0.28%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 6w ago | Court Ruling | $28.74 $22.38 | ▼ −22.13% | ▼ −20.18% | $22.07 (−23.21%) |
Aug 13, 2026 7w ago | 8-K | $28.15 $22.75 | ▼ −19.18% | ▼ −17.44% | $22.07 (−21.60%) |
Aug 6, 2026 8w ago | 8-K | $29.11 $23.70 | ▼ −18.58% | ▼ −19.18% | $22.07 (−24.18%) |
May 15, 2026 19w ago | Insider Cluster | $33.65 $34.65 | ▲ +2.97% | ▲ +1.39% | $22.07 (−34.41%) |
May 12, 2026 20w ago | Press Release | $35.69 $34.80 | ▼ −2.49% | ▼ −0.77% | $22.07 (−38.16%) |
May 11, 2026 20w ago | 144 | $35.81 $34.40 | ▼ −3.94% | ▼ −3.63% | $22.07 (−38.37%) |
Apr 23, 2026 23w ago | Press Release | $32.28 $34.22 | ▲ +6.01% | ▲ +1.38% | $22.07 (−31.63%) |
Apr 7, 2026 25w ago | 8-K | $33.43 $35.32 | ▲ +5.65% | ▼ −2.89% | $22.07 (−33.98%) |
Mar 19, 2026 28w ago | Press Release | $36.30 $34.41 | ▼ −5.21% | ▼ −12.83% | $22.07 (−39.20%) |
Mar 3, 2026 30w ago | Press Release | $39.99 $33.07 | ▼ −17.30% | ▼ −12.90% | $22.07 (−44.81%) |
Showing 10 of 12
US Market Status
Market Open — Closes in 3h 40m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access